Skip to content

The Yabble blog: Virtual Audiences

AI Personas for Market Research: Expert Q&A on Building, Bias & Best Practices

AI Personas for Market Research: Expert Q&A on Building, Bias & Best Practices

At Esomar's latest Community Circle, a panel of research experts assessed the pros and cons of qualitative AI personas. Our Chief Growth Officer Doug Guion joined them to discuss..

Read blog

Finding Your Brand White Space

#AIonPoint: Finding your Brand White Space: The Emotional Gap Insurance Brands Are Missing

Standing for what matters most to your consumers is a brand positioning fundamental, but it’s not always as easy as it sounds. Here we dive into that least trusted of categories –..

Read blog

Why Recurring Ad Characters Overperform

#AIonPoint: Why Recurring Ad Characters Overperform

What makes familiar faces such a great investment? In March 2026, we used Virtual Audiences to explore one of the most debated questions in brand strategy: is investing in a..

Read blog

Going Beyond The Billboard

#AIonPoint: Going Beyond the Billboard

How to get a WOW from your OOH Commuters in the tunnel connecting St Pancras and King's Cross St Pancras stations recently had the chance to smell an evolution in OOH advertising...

Read blog

#AIonPoint: How to Choose a Great Spokesperson For Your Brand

Lessons from Pizza Hut's Campaign with Tom Brady Choosing the wrong brand spokesperson doesn't just waste media budget — it can actively damage the brand you've spent years..

Read blog

#AIonPoint: When Does Celeb Drama Become Brand Risk?

Will "Brand Beckham" bend or break? Celebrity partnerships remain a powerful growth lever, but the landscape has evolved. The global celebrity and influencer collaboration market..

Read blog

How GLP-1 Drugs Are Transforming Consumer Behavior and What Businesses Should Do About It

How GLP-1 Drugs Are Transforming Consumer Behavior and What Businesses Should Do About It

This research was conducted on 12/17/25 and made possible using Virtual Audiences GLP-1 receptor agonists (medications like Ozempic, Wegovy, Mounjaro, and Zepbound) are no longer..

Read blog

Reflections On 2025: A Conversation With Doug Guion

Reflections On 2025: A Conversation With Doug Guion

The past 12 months have marked an inflection point for the insights industry. At the start of 2025, AI featured heavily in conversations but wasn't being used widely in practice...

Read blog

Virtual Audiences Just Got Even Better

Virtual Audiences just got even more powerful. With a cleaner workspace, smarter persona chats, and new ways to work quickly, getting actionable insights is easier than ever.

Read blog

Subscribe to our newsletter

Exciting product updates, the latest insights news, and more — delivered straight to your inbox.